Welcome to our dedicated page for Mangoceuticals news (Ticker: MGRX), a resource for investors and traders seeking the latest updates and insights on Mangoceuticals stock.
Mangoceuticals, Inc. (NASDAQ: MGRX) is frequently in the news for developments across telemedicine-based wellness, digital assets, and capital markets activity. The company describes itself as focused on developing, marketing, and selling men’s and women’s health and wellness products and services via secure telemedicine platforms under the MangoRx and PeachesRx brands, and its announcements reflect this multi-faceted strategy.
News updates about Mangoceuticals often highlight new or expanded programs on its telehealth platforms, including offerings related to erectile dysfunction, hair growth, hormone replacement therapies, and weight management. The company has issued releases describing MangoRx Direct and PeachesRx Direct weight-management programs, as well as the launch of PeachesRx as a women’s telehealth brand focused initially on GLP-1–based weight management solutions.
Investors following MGRX news will also see coverage of Mangoceuticals’ work on MGX-0024, a patented antiviral compound described as a blend of natural polyphenols and zinc evaluated in poultry field studies for respiratory diseases. Additional headlines have addressed the company’s acquisition of intellectual property from Smokeless Technology Corp. related to stimulant and functional pouches, and prior announcements concerning exclusive rights to the plant-based nutraceutical Diabetinol, followed by a later filing describing the mutual rescission of that agreement.
Mangoceuticals’ news flow further includes updates on its Solana-focused digital asset treasury strategy through Mango DAT, LLC in partnership with Cube Group, as well as financing transactions such as private placements, registered direct offerings, warrant exercises, and equity line drawdowns. For readers tracking MGRX, this news page provides a centralized view of company-issued press releases and related market-moving disclosures. Bookmark this page to review new Mangoceuticals announcements, product and program descriptions, and SEC-reported events as they are released.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
FAQ
What is the current stock price of Mangoceuticals (MGRX)?
What is the market cap of Mangoceuticals (MGRX)?
